Search results

  • Full text

  • Document type

    • Publication year

  • Organisation

Results: 50
Number of items: 50
  • Bartel, F., van Herk, M., Vrenken, H., Vandaele, F., Sunaert, S., de Jaeger, K., Dollekamp, N. J., Carbaat, C., Lamers, E., Dieleman, E. M. T., Lievens, Y., de Ruysscher, D., Schagen, S. B., de Ruiter, M. B., de Munck, J. C., & Belderbos, J. (2019). Inter-observer variation of hippocampus delineation in hippocampal avoidance prophylactic cranial irradiation. Clinical & translational oncology, 21(2), 178-186. https://doi.org/10.1007/s12094-018-1903-7
  • Open Access
    Witlox, L., Schagen, S. B., de Ruiter, M. B., Geerlings, M. I., Peeters, P. H. M., Koevoets, E. W., van der Wall, E., Stuiver, M., Sonke, G., Velthuis, M. J., van der Palen, J. A. M., Jobsen, J. J., May, A. M., & Monninkhof, E. M. (2019). Effect of physical exercise on cognitive function and brain measures after chemotherapy in patients with breast cancer (PAM study): protocol of a randomised controlled trial. BMJ Open, 9(6), Article e028117. https://doi.org/10.1136/bmjopen-2018-028117
  • Open Access
    Belderbos, J., De Ruysscher, D., De Jaeger, K., Koppe, F., Lambrecht, M., Lievens, Y., Dieleman, E., Jaspers, J., Van Meerbeeck, J., Ubbels, J., Kwint, M., Kuenen, M., Deprez, S., De Ruiter, M., Sikorska, K., Van Tinteren, H., & Schagen, S. (2019). Phase III trial of Prophylactic Cranial Irradiation with or without Hippocampus Avoidance in SCLC. Radiotherapy and oncology, 133(Supplement 1), S259. Article OC-0503. https://doi.org/10.1016/S0167-8140(19)30923-5
  • Open Access
    Liu, Y., van den Wildenberg, W. P. M., de Graaf, Y., Ames, S. L., Baldacchino, A., Bø, R., Cadaveira, F., Campanella, S., Christiansen, P., Claus, E. D., Colzato, L. S., Filbey, F. M., Foxe, J. J., Garavan, H., Hendershot, C. S., Hester, R., Jester, J. M., Karoly, H. C., Kräplin, A., ... Wiers, R. W. (2019). Is (poly-) substance use associated with impaired inhibitory control? A mega-analysis controlling for confounders. Neuroscience and Biobehavioral Reviews, 105, 288-304. https://doi.org/10.1016/j.neubiorev.2019.07.006
  • Stouten-Kemperman, M. M., de Ruiter, M. B., Boogerd, W., Kerst, J. M., Kirschbaum, C., Reneman, L., & Schagen, S. B. (2018). Brain Hyperconnectivity >10 Years After Cisplatin-Based Chemotherapy for Testicular Cancer. Brain Connectivity, 8(7), 398-406. https://doi.org/10.1089/brain.2017.0569
  • Deprez, S., de Ruiter, M. B., Bogaert, S., Peeters, R., Belderbos, J., De Ruysscher, D., Schagen, S., Sunaert, S., Pullens, P., & Achten, E. (2018). Multi-center reproducibility of structural, diffusion tensor, and resting state functional magnetic resonance imaging measures. Neuroradiology, 60(6), 617-634. https://doi.org/10.1007/s00234-018-2017-1
  • Menning, S., de Ruiter, M. B., Veltman, D. J., Boogerd, W., Oldenburg, H. S. A., Reneman, L., & Schagen, S. B. (2018). Changes in brain white matter integrity after systemic treatment for breast cancer: a prospective longitudinal study. Brain imaging and behavior, 12(2), 324-334. https://doi.org/10.1007/s11682-017-9695-x
  • Menning, S., de Ruiter, M., Veltman, D. J., Boogerd, W., Oldenburg, H. S., Reneman, L., & Schagen, S. B. (2017). Demographics, PROs and fMRI task data [Data set]. Figshare. https://doi.org/10.6084/m9.figshare.4670545.v1
  • Belderbos, J., Schagen, S., Walraven, I., Deprez, S., de Ruiter, M., De Ruysscher, D., & Le Pechoux , C. (2017). In Regard to Redmond et al. International Journal of Radiation Oncology Biology Physics, 99(1), 238-239. https://doi.org/10.1016/j.ijrobp.2017.05.012
  • Open Access
    Menning, S., de Ruiter, M. B., Veltman, D. J., Boogerd, W., Oldenburg, H. S. A., Reneman, L., & Schagen, S. B. (2017). Changes in brain activation in breast cancer patients depend on cognitive domain and treatment type. PLoS ONE, 12(3), Article e0171724. https://doi.org/10.1371/journal.pone.0171724
Page 3 of 5